Last reviewed · How we verify
NCT02482623: DSM-H
The Dementia Symptom Management at Home Program
NA trial testing Dementia Symptom Management at Home Program in Dementia. Withdrawn.
1 March 2018
Quick facts
| Lead sponsor | New York University |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Start date | 1 August 2017 |
| Primary completion | 1 March 2018 |
| Estimated completion | 1 March 2018 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Dementia Symptom Management at Home Program
Conditions studied
- Dementia — all drugs for Dementia →
Sponsor
New York University
Who can join
65 and older, any sex, with Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Persons with dementia and their caregivers are often cared for in the community through home healthcare (HHC). While these patients and their caregivers need significant help and often have difficulty maintaining their quality of life, home healthcare clinicians are often unprepared to care for this population. This study will therefore examine the ability of an integrated, multi-pronged evidence-based practice intervention for home healthcare registered nurses, occupational therapists and physical therapists, the DSM-H, to improve the quality of care and quality of life for persons with dementia and their family caregiver. The investigators will enroll persons with dementia and their family caregiver upon admission to the HHC agency and examine their quality of life over 60 days following admission, comparing those who receive the intervention to those who serve as controls.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02482623
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dementia
Currently open trials in the same condition.
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
- NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
- NCT06088810 — The Impact of Music Intervention on Sleep · NA · recruiting
- NCT07482800 — Dementia in Fiction and Clinical Narratives · recruiting
- NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting
Other New York University trials
Trials by the same sponsor.
- NCT07526246 — Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect · NA · not yet recruiting
- NCT07519941 — Promoting Change in Practice for Respiratory Failure · NA · not yet recruiting
- NCT07071753 — Optimizing Online Purchasing of Fruits, Vegetables, and Legumes for Low-Income Families · NA · not yet recruiting
- NCT07530900 — Prediction of Visual Feedback Effects on Speech Motor Adaptation in Healthy Adults · NA · not yet recruiting
- NCT07278934 — Testing the Impact of Family-Based Intervention to Improve Developmental and Health Outcomes for Female Adolescents · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02482623 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New York University
- Last refreshed: 2 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02482623.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing